Načítá se...
Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS‐CoV‐2 (COVID‐19) pandemic emergency: A quick review for a quick consultation
The precision medicine era has helped to better manage patients with immunological and oncological diseases, improving the quality of life of this class of patients. Regarding the management of these patients and positivity to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), currently,...
Uloženo v:
| Vydáno v: | Dermatol Ther |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261970/ https://ncbi.nlm.nih.gov/pubmed/32385891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13537 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|